CASP3 and cancer: The dose-dependent activation of Caspase-3 suggests that stigmasterol can induce apoptosis in cancer cells via mitochondria-mediated pathway, while the disruption of ΔΨm via depolarization under the action of stigmasterol in a dose-dependent fashion is considered as an essential prerequisite of activation of apoptosis (58, 59).